Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Red rash; This non-serious case was reported by a consumer and described the occurrence of red rash in a 68-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Concurrent medical conditions included asthma and allergy. Concomitant products included mometasone furoate (Asmanex) and levocetirizine dihydrochloride (Allegra). On 31-OCT-2025, the patient received Shingles vaccine. On 12-DEC-2025, 42 days after receiving Shingles vaccine, the patient experienced red rash (Verbatim: Red rash). The patient was treated with triamcinolone diacetate (Triamcinolone). The outcome of the red rash was not resolved. It was unknown if the reporter considered the red rash to be related to Shingles vaccine. It was unknown if the company considered the red rash to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 21-JAN-2026 The red rash was treated. The batch number was not provided and a request for this information has been made.
Allergy; Asthma
Asmanex; Allegra